Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hardik Rana"'
Autor:
Hardik Rana, Priyanka Pathak, Vimal Patel, Vaishali Thakkar, Mansi Dholakia, Saloni Dalwadi, Tejal Gandhi
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 10, Iss 1, Pp 1-16 (2024)
Abstract Background The intersubject variability which was related to the genetic makeup was the major cause of change in pharmacological and pharmacokinetic behavior of same dosage form in varied human being. 3D printing technology will help therapy
Externí odkaz:
https://doaj.org/article/7179c9b396cd49ae9fecdca2861c9789
Publikováno v:
Results in Chemistry, Vol 10, Iss , Pp 101753- (2024)
Background: Sol-Gel is the conventional approach for in-situ formulation having several limitations, including instability, stringent storage conditions, dose inaccuracy, inconsistent drug release, and patient inconvenience. Objectives: The aim of th
Externí odkaz:
https://doaj.org/article/3893989c202948d4a130a9ae846a0b0f
Publikováno v:
Heliyon, Vol 10, Iss 8, Pp e29543- (2024)
Tadalafil (TDL) has poor bioavailability due to the less aqueous solubility and bitter taste. Oral solid dosage forms, especially tablets, have a broad market worldwide. Constraints of tablets are a long process, pollution, high processing cost, and
Externí odkaz:
https://doaj.org/article/685beaa7a8714cd8a4ea0aef5d0db36f
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 9, Iss 1, Pp 1-17 (2023)
Abstract Background Chronic conditions such as nocturnal asthma, cardiac disorder, diabetes mellitus, joint pain and inflammation, and hypercholesterolemia necessitate a treatment strategy that can be planned in accordance with the disease's biologic
Externí odkaz:
https://doaj.org/article/d12858fa75e74b6d843781b18349e15c
Publikováno v:
Annals of 3D Printed Medicine, Vol 13, Iss , Pp 100144- (2024)
Personalized medicine is the need of today's era, as one therapy does not fit all. The study aims to develop a novel patient-customized formulation using the integration of 3-D printing and Nanotechnology concepts. Valsartan (VLS) was chosen as a mod
Externí odkaz:
https://doaj.org/article/ba3eb2d07dd14150b0114daa37768f0f
Publikováno v:
Food Hydrocolloids for Health, Vol 4, Iss , Pp 100144- (2023)
The research was undertaken to design, develop and characterize the smart lipid system of an inadequate bioavailable Atovaquone (ATQ). The poor aqueous solubility and dissolution are the major constrain of inadequate bioavailability. The solubility s
Externí odkaz:
https://doaj.org/article/92bd01ecc1a54256aeca783e2a9083bf
Publikováno v:
Current Drug Therapy. 18:433-444
Background: Febuxostat is a BCS class-II drug, used in the treatment of gout. However, because of its lower solubility, a higher and more frequent dose of the drug is required in the treatment. Objective: The objective of this research was to develop
Publikováno v:
Current Drug Therapy. 18:117-131
Background: Now-a-day, there is the need to explore the concept of green chemistry in every field. Many existing conventional and novel drug delivery systems have problems related to green chemistry. To overcome the existing limitations of the differ
Publikováno v:
International Journal Of Medical Science And Clinical Invention.
Recognition of unusual variations in the root canal system is critical because it has been established that the root with a single tapering canal and apical foramen is the exception rather than the rule. C-shaped canal system is a variation that has